The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH-mutant gliomas

Neuro Oncol. 2024 Mar 4;26(3):403-406. doi: 10.1093/neuonc/noad240.

Authors

Nathalie L Albert¹, Julia Furtner², Martin J van den Bent³, Matthias Preusser⁴

Affiliations

¹ Department of Nuclear Medicine, LMU Hospital, LMU Munich, Munich, Germany.
² Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Faculty of Medicine and Dentistry, Danube Private University, Krems, Austria.
³ The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁴ Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

No abstract available

MeSH terms

Amino Acids
Brain Neoplasms* / diagnostic imaging
Brain Neoplasms* / drug therapy
Brain Neoplasms* / genetics
Diamines
Glioma* / diagnostic imaging
Glioma* / drug therapy
Glioma* / genetics
Humans
Isocitrate Dehydrogenase / genetics
Mutation
Positron-Emission Tomography
Pyridines*

Substances

vorasidenib
Amino Acids
Diamines
Isocitrate Dehydrogenase
Pyridines